Literature DB >> 33125456

Reply to Mikulska et al.

Jeffrey D Jenks1,2,3, Juergen Prattes4, Dieter Buchheidt5, Martin Hoenigl2,3,4.   

Abstract

Entities:  

Year:  2021        PMID： 33125456      PMCID： PMC8492206          DOI： 10.1093/cid/ciaa1670

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  10 in total

1.  Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage.

Authors:  Jeffrey D Jenks; Sanjay R Mehta; Randy Taplitz; Saima Aslam; Sharon L Reed; Martin Hoenigl
Journal:  Mycoses       Date:  2019-01-15       Impact factor: 4.377

2.  Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study.

Authors:  Toine Mercier; Albert Dunbar; Elizabeth de Kort; Alexander Schauwvlieghe; Marijke Reynders; Ellen Guldentops; Nicole M A Blijlevens; Alieke G Vonk; Bart Rijnders; Paul E Verweij; Katrien Lagrou; Johan Maertens
Journal:  Med Mycol       Date:  2020-06-01       Impact factor: 4.076

3.  Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies.

Authors:  Jeffrey D Jenks; Sanjay R Mehta; Randy Taplitz; Nancy Law; Sharon L Reed; Martin Hoenigl
Journal:  J Infect       Date:  2018-11-02       Impact factor: 6.072

4.  Point-of-care diagnostics for invasive aspergillosis: nearing the finish line.

Authors:  Jeffrey D Jenks; Martin Hoenigl
Journal:  Expert Rev Mol Diagn       Date:  2020-09-14       Impact factor: 5.225

5.  Evaluation of the Performance of the IMMY sona Aspergillus Galactomannan Lateral Flow Assay When Testing Serum To Aid in Diagnosis of Invasive Aspergillosis.

Authors:  P Lewis White; Jessica S Price; Raquel Posso; Morgan Cutlan-Vaughan; Lorna Vale; Matthijs Backx
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

6.  Prospective Evaluation of the Turbidimetric β-D-Glucan Assay and 2 Lateral Flow Assays on Serum in Invasive Aspergillosis.

Authors:  Toine Mercier; Ellen Guldentops; Katrien Lagrou; Johan Maertens
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

Review 7.  COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment.

Authors:  Amir Arastehfar; Agostinho Carvalho; Frank L van de Veerdonk; Jeffrey D Jenks; Philipp Koehler; Robert Krause; Oliver A Cornely; David S Perlin; Cornelia Lass-Flörl; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2020-06-24

8.  Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores.

Authors:  Martin Hoenigl
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079
  10 in total
  1 in total

1.  Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans.

Authors:  Genna E Davies; Christopher R Thornton
Journal:  J Fungi (Basel)       Date:  2022-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.